3.37 USD
-0.03 (-0.88%)
3.38 USD
+0.01 (+0.3%)
ChartMill assigns a Buy % Consensus number of 83% to ACST. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 8.16. This target is 142.14% above the current price.
- ACST was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about ACST.
- In the previous month the buy percentage consensus was at a similar level.
- ACST was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-09-26 | Craig-Hallum | Maintains | Buy -> Buy |
| 2024-09-26 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-02-07 | Craig-Hallum | Initiate | Buy |
| 2023-02-15 | EF Hutton | Reiterate | Buy |
| 2022-12-19 | EF Hutton | Initiate | Buy |
| 2022-12-15 | HC Wainwright & Co. | Initiate | Buy |
| 2021-12-22 | Oppenheimer | Initiate | Outperform |
| 2021-12-21 | Oppenheimer | Initiate | Outperform |
ACASTI PHARMA INC / ACST FAQ
Can you provide the average price target for ACASTI PHARMA INC stock?
7 analysts have analysed ACST and the average price target is 8.16 USD. This implies a price increase of 142.14% is expected in the next year compared to the current price of 3.37.
Can you provide the consensus rating for ACASTI PHARMA INC stock?
The consensus rating for ACASTI PHARMA INC (ACST) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.
Can you provide the analyst count for ACASTI PHARMA INC stock?
The number of analysts covering ACASTI PHARMA INC (ACST) is 7.